Pfizer Limited
Pfizer Limited is an Indian listed company in the Pharmaceuticals & Biotechnology industry (Healthcare sector), traded under NSE: PFIZER and BSE: 500680 (ISIN INE182A01018).
It has a market capitalisation of ₹17,425 crore, a last close of ₹3,809 on 2026-10-19, a one-year return of -28.9%.
Valuation: a price-to-earnings ratio of 23.70x, a price-to-book ratio of 4.15x, a dividend yield of 2.0%.
Profitability: return on equity of 17.2%, return on capital employed of 22.8%, an operating margin of 36.6%.
Growth: sales growth of 1.3% a year over three years, net profit growth of 5.0% a year over three years.
Balance sheet and ownership: debt-to-equity of 0.00x, promoter holding of 63.9%.
| Metric | Value |
|---|---|
| Market capitalisation | 17,425 |
| Last close | ₹3,809 |
| P/E (TTM) | 23.70x |
| P/B | 4.15x |
| Dividend yield | 2.0% |
| ROE (FY) | 17.2% |
| ROCE (FY) | 22.8% |
| Operating margin (TTM) | 36.6% |
| Sales growth, 3-year CAGR | 1.3% |
| Profit growth, 3-year CAGR | 5.0% |
| Debt / equity | 0.00x |
| Promoter holding | 63.9% |
| 1-year return | -28.9% |
Loading the live page with the price chart, financial history, shareholding and recent filings. Data is end-of-day and rebuilt nightly; nothing here is investment advice. Financial statements · What each metric means